Brought to you by 
Merck and Simcere form JV in China; Simcere takes over its management
09 Feb 2015
Executive Summary
Merck & Co. Inc. (Merck Sharp & Dohme (MSD) outside of the US) and Simcere Pharmaceutical Group (branded and generic drugs) have agreed to form a new company in China that will be 51% owned by Merck and the remainder by Simcere.
Deal Industry
- Pharmaceuticals
Deal Status
- Concluded
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck and Simcere form JV in China; Simcere takes over its management
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice